BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32626975)

  • 21. Increased fibroblast telomerase expression precedes myofibroblast α-smooth muscle actin expression in idiopathic pulmonary fibrosis.
    Waisberg DR; Parra ER; Barbas-Filho JV; Fernezlian S; Capelozzi VL
    Clinics (Sao Paulo); 2012 Sep; 67(9):1039-46. PubMed ID: 23018301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hsp90 regulation of fibroblast activation in pulmonary fibrosis.
    Sontake V; Wang Y; Kasam RK; Sinner D; Reddy GB; Naren AP; McCormack FX; White ES; Jegga AG; Madala SK
    JCI Insight; 2017 Feb; 2(4):e91454. PubMed ID: 28239659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BET-inhibition by JQ1 alleviates streptozotocin-induced diabetic cardiomyopathy.
    Guo M; Wang HX; Chen WJ
    Toxicol Appl Pharmacol; 2018 Aug; 352():9-18. PubMed ID: 29782963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulated expression of hypoxia-inducible factors augments myofibroblasts differentiation in idiopathic pulmonary fibrosis.
    Aquino-Gálvez A; González-Ávila G; Jiménez-Sánchez LL; Maldonado-Martínez HA; Cisneros J; Toscano-Marquez F; Castillejos-López M; Torres-Espíndola LM; Velázquez-Cruz R; Rodríguez VHO; Flores-Soto E; Solís-Chagoyán H; Cabello C; Zúñiga J; Romero Y
    Respir Res; 2019 Jun; 20(1):130. PubMed ID: 31234835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of human PDGFR-β-positive pericytes from IPF and non-IPF lungs.
    Wilson CL; Stephenson SE; Higuero JP; Feghali-Bostwick C; Hung CF; Schnapp LM
    Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L991-L1002. PubMed ID: 30335500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosome-Derived microRNA-22 Ameliorates Pulmonary Fibrosis by Regulating Fibroblast-to-Myofibroblast Differentiation in Vitro and in Vivo.
    Kuse N; Kamio K; Azuma A; Matsuda K; Inomata M; Usuki J; Morinaga A; Tanaka T; Kashiwada T; Atsumi K; Hayashi H; Saito Y; Seike M; Gemma A
    J Nippon Med Sch; 2020 Jul; 87(3):118-128. PubMed ID: 31776321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-27a-3p Is a Negative Regulator of Lung Fibrosis by Targeting Myofibroblast Differentiation.
    Cui H; Banerjee S; Xie N; Ge J; Liu RM; Matalon S; Thannickal VJ; Liu G
    Am J Respir Cell Mol Biol; 2016 Jun; 54(6):843-52. PubMed ID: 26600197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrix Metalloproteinases Retain Soluble FasL-mediated Resistance to Cell Death in Fibrotic-Lung Myofibroblasts.
    Nareznoi D; Konikov-Rozenman J; Petukhov D; Breuer R; Wallach-Dayan SB
    Cells; 2020 Feb; 9(2):. PubMed ID: 32053892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin attenuates lung fibrosis development via NOX4 suppression.
    Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
    Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.
    Pardo A; Selman M
    Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S417-S421. PubMed ID: 28005427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
    Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
    Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis.
    Leppäranta O; Pulkkinen V; Koli K; Vähätalo R; Salmenkivi K; Kinnula VL; Heikinheimo M; Myllärniemi M
    Am J Respir Cell Mol Biol; 2010 May; 42(5):626-32. PubMed ID: 19597127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro.
    Joannes A; Brayer S; Besnard V; Marchal-Sommé J; Jaillet M; Mordant P; Mal H; Borie R; Crestani B; Mailleux AA
    Am J Physiol Lung Cell Mol Physiol; 2016 Apr; 310(7):L615-29. PubMed ID: 26773067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting MAP3K19 prevents human lung myofibroblast activation both in vitro and in a humanized SCID model of idiopathic pulmonary fibrosis.
    Jones IC; Espindola MS; Narayanan R; Coelho AL; Habiel DM; Boehme SA; Ly TW; Bacon KB; Hogaboam CM
    Sci Rep; 2019 Dec; 9(1):19796. PubMed ID: 31875033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial Microparticles are Associated to Pathogenesis of Idiopathic Pulmonary Fibrosis.
    Bacha NC; Blandinieres A; Rossi E; Gendron N; Nevo N; Lecourt S; Guerin CL; Renard JM; Gaussem P; Angles-Cano E; Boulanger CM; Israel-Biet D; Smadja DM
    Stem Cell Rev Rep; 2018 Apr; 14(2):223-235. PubMed ID: 29101610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of the SET8 Pathway Ameliorates Lung Fibrosis Even Through Fibroblast Dedifferentiation.
    Ugai K; Matsuda S; Mikami H; Shimada A; Misawa T; Nakamura H; Tatsumi K; Hatano M; Murayama T; Kasuya Y
    Front Mol Biosci; 2020; 7():192. PubMed ID: 32850975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis.
    Kheirollahi V; Wasnick RM; Biasin V; Vazquez-Armendariz AI; Chu X; Moiseenko A; Weiss A; Wilhelm J; Zhang JS; Kwapiszewska G; Herold S; Schermuly RT; Mari B; Li X; Seeger W; Günther A; Bellusci S; El Agha E
    Nat Commun; 2019 Jul; 10(1):2987. PubMed ID: 31278260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis.
    Wygrecka M; Kwapiszewska G; Jablonska E; von Gerlach S; Henneke I; Zakrzewicz D; Guenther A; Preissner KT; Markart P
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1703-14. PubMed ID: 21471103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MeCP2 epigenetically regulates alpha-smooth muscle actin in human lung fibroblasts.
    Xiang Z; Zhou Q; Hu M; Sanders YY
    J Cell Biochem; 2020 Jul; 121(7):3616-3625. PubMed ID: 32115750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix abnormalities in pulmonary fibrosis.
    Upagupta C; Shimbori C; Alsilmi R; Kolb M
    Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29950306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.